This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Clinical Services

Clinical Manufacturing

PCI offers a broad range of services to address the manufacturing needs of our clients at each stage of the product lifecycle. Central to PCI’s international service offering is our capability to manufacture a range of dosage forms in compliance with current GMP standards.

For over 30 years, we have been successfully developing pharmaceutical dosage forms. Our strength lies in the integrated nature of our services, combining formulation development and analytical services with clinical trial supplies for potent, non-potent, Schedule 8 & 9 and sterile dosage forms. This comprehensive yet flexible package is delivered with close coordination of each stage of the development process by our experienced project management team.

Our facilities have been designed to allow flexibility in processing technology and are approved for the manufacture of investigational and commercial products. With a comprehensive range of qualified analytical equipment and extensive stability storage resources, we are able to develop and validate analytical methods to support development programs.

By combining formulation and analytical testing with GMP clinical trial manufacturing and packaging, we are able to offer a seamless service throughout your development journey.

Our dedicated team of specialists will be happy to discuss any of your Clinical Manufacturing needs. Contact us on +1 779-774-1428 (US) or +44 1495 713 633 (UK) or email sales@pciservices.com


PCI Clinical Services to Showcase Expertise in Phase I Clinical Trials in Australia

PCI will showcase our expertise in Phase I Clinical Trials in Australia with a series of West Coast US seminars... View Article

Success at Aspire Blaenau Gwent Shared Apprenticeship Awards

PCI is celebrating two wins in the Aspire Blaenau Gwent Shared Apprenticeship Program Awards 2018. PCI as an organization and... View Article

x